The FDA refusal to allow 4 shots was a CLEAR signa

Quote:

---

The FDA refusal to allow 4 shots was a CLEAR signal for Nader, his MDs and us, the longs that the BP/FDA trap had been set and ready to go.

---

There was no trap. The FDA thought that leronlimab was an immunosuppressor most likely based on the fact that it blocked a main promoter of the immune system. If they had actually read the literature on CCR5 blockade they would have seen that it would promote the recovery of CD4 and CD8 macrophages aiding in the ability to fight viruses. Strangely, corticosteroids would have been in use with many patients in both arms of the trial and it is an immunosuppressor. Under the trial protocol corticosteroids could have been used by patients before and during all four weeks of the trial.